Jongmin Park Selected Research

ampkinone

10/2010

Antidiabetic and antiobesity effects of Ampkinone (6f), a novel small molecule activator of AMP-activated protein kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jongmin Park Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 05/2007
3	Inflammation (Inflammations) 01/2018 - 12/2014
2	Brain Ischemia (Cerebral Ischemia) 11/2021 - 04/2011
2	Cognitive Dysfunction 10/2021 - 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	COVID-19 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Starvation 01/2021
1	Emphysema 01/2021
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2021
1	Adenocarcinoma 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Myocardial Infarction 01/2018
1	Food Hypersensitivity (Food Allergy) 10/2017
1	Celiac Disease (Celiac Sprue) 10/2017
1	Neuroinflammatory Diseases 12/2014
1	Stomach Neoplasms (Stomach Cancer) 05/2012
1	Ovarian Neoplasms (Ovarian Cancer) 05/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2012
1	Breast Neoplasms (Breast Cancer) 05/2012
1	Brain Injuries (Brain Injury) 04/2011
1	Type 2 Diabetes Mellitus (MODY) 10/2010
1	Obesity 10/2010
1	Body Weight (Weight, Body) 10/2010
1	Prostatic Neoplasms (Prostate Cancer) 04/2010
1	Carcinoma (Carcinomatosis) 08/2009
1	Lung Neoplasms (Lung Cancer) 06/2009
1	Carcinogenesis 06/2009
1	Anaphylaxis (Anaphylactic Shock) 08/2004
1	Asthma (Bronchial Asthma) 06/2002

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2016
3	Neuroprotective AgentsIBA 10/2021 - 04/2011
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2009
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2021
2	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019 - 08/2009
2	CytokinesIBA 01/2018 - 01/2018
1	Sirtuin 1IBA 11/2021
1	ParvalbuminsIBA 10/2021
1	CalciumIBA 10/2021
1	Calbindin 1IBA 10/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Epithelial Cell Adhesion MoleculeIBA 01/2021
1	AntibodiesIBA 01/2021
1	ChromatinIBA 01/2021
1	Pharmaceutical PreparationsIBA 02/2018
1	Interleukin-3 (Interleukin 3)IBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2017
1	HMGB2 ProteinIBA 12/2014
1	HMGB1 Protein (HMG1)IBA 12/2014
1	tyrosine receptor (receptor, tyrosine)IBA 05/2012
1	HM781-36BIBA 05/2012
1	ErbB Receptors (EGF Receptor)IBA 05/2012
1	Phosphotransferases (Kinase)IBA 05/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2012
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2012
1	Tyrosine Kinase InhibitorsIBA 05/2012
1	AMP-Activated Protein KinasesIBA 10/2010
1	Adenosine (Adenocard)FDA LinkGeneric 10/2010
1	ampkinoneIBA 10/2010
1	Androgen Antagonists (Antiandrogens)IBA 04/2010
1	Androgen Receptor AntagonistsIBA 04/2010
1	BenzopyransIBA 04/2010
1	FluoridesIBA 08/2009
1	AerosolsIBA 06/2009
1	cyclic 3',5'-thymidine monophosphate (cTMP)IBA 06/2009
1	Photosensitizing Agents (Photosensitizers)IBA 05/2007
1	AntigensIBA 08/2004
1	saikosaponin DIBA 06/2002
1	TriterpenesIBA 06/2002
1	GlycosidesIBA 06/2002

Therapy/Procedure

2	Therapeutics 01/2021 - 06/2009
1	Adjuvant Chemotherapy 01/2019
1	Neoadjuvant Therapy 01/2019